Cite
HARVARD Citation
Patel, A. et al. (2020). Cost‐Effectiveness of Combination Disease‐Modifying Antirheumatic Drugs Versus Tumor Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: A Pragmatic, Randomized, Multicenter Trial. Arthritis care & research. 72 (3), pp. 334-342. [Online].